A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University of Michigan Cancer Center
Sponsor:
Information provided by (Responsible Party):
Mark Zalupski, M.D., University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT01663272
First received: July 24, 2012
Last updated: January 17, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)